By Nascent Biotech Posted July 27, 2018 In BJCR-104(10) copy2018-07-272018-07-27http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 Recent PostsNascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical ResearchNascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerNascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patent
